StockVS

GridAI Technologies Corp. (GRDX) Aandelenanalyse

Gezondheidszorg

GridAI Technologies Corp.

$4.61

$-0.23 (-4.75%)

Laatst bijgewerkt: 26 mei 2026

Koersverloop

Analyse

Bedrijfsoverzicht

GridAI Technologies Corp. (GRDX) is a biotechnology firm operating within the healthcare sector that specializes in designing and developing an artificial intelligence-driven software and device platform. This platform is engineered to assist utilities, retailers, and large power users in managing load and distributed energy resources through advanced Aggregation Management capabilities. The company leverages Internet of Things (IoT) technology, artificial intelligence, machine learning, and edge computing to optimize energy distribution and resource management. As of the latest available data, the entity holds a market capitalization of $7.03 million, while specific figures regarding annual revenue and employee count are not disclosed in the current financial records. These valuation metrics indicate that the company operates on a micro-cap scale, suggesting a smaller market presence and limited operational footprint relative to larger industry peers. The absence of disclosed revenue and employee data further implies that the company is in an early-stage development phase where traditional scale metrics have not yet been fully realized or reported to public standards.

Financiële gezondheid

The financial statements for GridAI Technologies Corp. do not disclose specific figures for revenue, net income, or EBITDA over the trailing twelve-month period, indicating that the company has not yet generated sufficient profitable operations to report these standard metrics. Consequently, the gap between revenue and net income cannot be analyzed because both values are unavailable, leaving the cost structure opaque to external observers. The company also reports no free cash flow, which means there is currently no internal cash generation to fund capital expenditures or research initiatives without reliance on external financing. All three key margin metrics—gross margin, operating margin, and profit margin—are reported at 0.0%, reflecting a state where the company has not yet achieved commercial profitability or has not recognized any net earnings. Regarding liquidity and leverage, the available facts do not provide specific numbers for total cash or total debt, making a direct comparison impossible under current reporting standards. Similarly, the debt-to-equity ratio is listed as N/A, preventing an assessment of whether the balance sheet is conservative or leveraged. The current ratio is also unavailable, which precludes an evaluation of the company's ability to meet short-term obligations with short-term assets. Furthermore, return on equity and return on assets are not calculable due to the lack of reported net income and total equity or asset figures. These missing return metrics reveal that management effectiveness in generating returns on shareholder capital or total assets cannot be quantified at this stage.

Waarderingsbeoordeling

The trailing P/E ratio and forward P/E ratio for GridAI Technologies Corp. are both listed as N/A, which implies that earnings-based valuation multiples cannot be calculated due to the absence of net income. Without a price-to-book ratio, it is impossible to determine if the market is pricing the stock at a premium or discount relative to the company's book value per share. Similarly, the price-to-sales ratio and EV/EBITDA multiple are unavailable, suggesting that alternative valuation metrics typically used for high-growth or loss-making companies are not applicable or disclosed in this instance. In terms of price volatility, the stock has traded within a range defined by a 52-week high of $5.84 and a 52-week low of $0.97. While the exact current trading price is not explicitly stated in the provided facts to allow for a percentage calculation, the wide disparity between the high and low suggests significant price fluctuation over the past year. The beta value is not available, which prevents an analysis of how the stock's volatility compares to the broader market index. The absence of these specific valuation multiples and volatility metrics indicates that traditional valuation models are not currently applicable to this specific equity instrument.

Growth & Income

Revenue growth year-over-year and earnings growth year-over-year are both reported as N/A, meaning there is no historical data available to compare current performance against the previous year. Since earnings and revenue are not disclosed, it is not possible to determine if earnings are growing faster or slower than revenue, nor can implications regarding efficiency be drawn. The company does not pay a dividend, as indicated by a dividend yield of N/A and a payout ratio of 0.0%. This 0.0% payout ratio confirms that the company reinvests all available resources into its operations and research rather than distributing income to shareholders. Because there are no reported earnings, the sustainability of a potential future dividend cannot be assessed, and the current strategy clearly favors capital retention over income distribution. The overall growth and income profile is characterized by a complete absence of historical growth data and no current income generation, positioning the asset purely as a speculative venture with no established track record of financial expansion or shareholder returns.

Vergelijking met sectorgenoten

GridAI Technologies Corp. (GRDX) is actief in de Biotechnologie-sector. Zo verhoudt het zich tot de naaste sectorgenoten op basis van marktkapitalisatie:

Bedrijf Ticker Marktkapitalisatie K/W-verhouding
GridAI Technologies Corp. GRDX $28.58M N/A
Vertex Pharmaceuticals Incorporated VRTX $110.64B 25.8
Regeneron Pharmaceuticals, Inc. REGN $66.98B 15.6
argenx SE ARGX $50.52B 36.0

De gemiddelde K/W-verhouding in de Biotechnologie-sector is 53.8x. GridAI Technologies Corp. wordt verhandeld tegen een K/W van N/A.

Deze analyse is gegenereerd door AI en dient alleen ter informatie. Het vormt geen financieel advies. Gegevens kunnen vertraagd of onnauwkeurig zijn. Doe altijd je eigen onderzoek en raadpleeg een gekwalificeerde financieel adviseur voordat je beleggingsbeslissingen neemt.

Over GridAI Technologies Corp.

GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.

Bedrijfsbeschrijving wordt in het Engels weergegeven.

Bezoek website →

Belangrijke Cijfers

Marktkapitalisatie
$28.58M
K/W-verhouding
N/A
52-weken hoog
$5.84
52-weken laag
$1.06
Gem. Volume
112.68K

Gegevens verstrekt door Yahoo Finance via yfinance. Dagelijks bijgewerkt.

Bedrijfsinfo

Beurs
NASDAQ
Land
United Kingdom